Cite
Osteopontin as a biomarker for osteosarcoma therapy and prognosis.
MLA
Han, Xingwen, et al. “Osteopontin as a Biomarker for Osteosarcoma Therapy and Prognosis.” Oncology Letters, vol. 17, no. 3, Mar. 2019, pp. 2592–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135075451&authtype=sso&custid=ns315887.
APA
Han, X., Wang, W., He, J., Jiang, L., & Li, X. (2019). Osteopontin as a biomarker for osteosarcoma therapy and prognosis. Oncology Letters, 17(3), 2592–2598.
Chicago
Han, Xingwen, Wenji Wang, Jingjing He, Lei Jiang, and Xun Li. 2019. “Osteopontin as a Biomarker for Osteosarcoma Therapy and Prognosis.” Oncology Letters 17 (3): 2592–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135075451&authtype=sso&custid=ns315887.